Granite Fo LLC Abb Vie Inc. Transaction History

Granite Fo LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 05, 2024	SELL	$132.51 - $164.9 $11,395 - $14,181	-86 Reduced 76.11%	27 $3.64 Million
Q1 2023 Sep 05, 2024	BUY	$144.61 - $166.54 $3,759 - $4,330	26 Added 29.89%	113 $17.1 Million
Q4 2022 Sep 05, 2024	BUY	$138.31 - $165.87 $12,032 - $14,430	87 New	87 $14 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Fo LLC with notifications on news.